3898 related articles for article (PubMed ID: 30025574)
1. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
[TBL] [Abstract][Full Text] [Related]
2. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
[TBL] [Abstract][Full Text] [Related]
4. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
[TBL] [Abstract][Full Text] [Related]
6. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
[TBL] [Abstract][Full Text] [Related]
7. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
8. Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials.
Sotomi Y; Onuma Y; Cavalcante R; Ahn JM; Lee CW; van Klaveren D; de Winter RJ; Wykrzykowska JJ; Farooq V; Morice MC; Steyerberg EW; Park SJ; Serruys PW
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495897
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome.
Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
Am J Cardiol; 2017 Aug; 120(3):380-386. PubMed ID: 28595861
[TBL] [Abstract][Full Text] [Related]
10. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
[TBL] [Abstract][Full Text] [Related]
11. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.
Modolo R; Chichareon P; Kogame N; Dressler O; Crowley A; Ben-Yehuda O; Puskas J; Banning A; Taggart DP; Kappetein AP; Sabik JA; Onuma Y; Stone GW; Serruys PW
J Am Coll Cardiol; 2019 Apr; 73(15):1877-1886. PubMed ID: 30999989
[TBL] [Abstract][Full Text] [Related]
12. Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
Park DW; Ahn JM; Park H; Yun SC; Kang DY; Lee PH; Kim YH; Lim DS; Rha SW; Park GM; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ;
Circulation; 2020 May; 141(18):1437-1446. PubMed ID: 32223567
[TBL] [Abstract][Full Text] [Related]
13. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
Kosmidou I; Chen S; Kappetein AP; Serruys PW; Gersh BJ; Puskas JD; Kandzari DE; Taggart DP; Morice MC; Buszman PE; Bochenek A; Schampaert E; Pagé P; Sabik JF; McAndrew T; Redfors B; Ben-Yehuda O; Stone GW
J Am Coll Cardiol; 2018 Feb; 71(7):739-748. PubMed ID: 29447735
[TBL] [Abstract][Full Text] [Related]
14. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.
Milojevic M; Serruys PW; Sabik JF; Kandzari DE; Schampaert E; van Boven AJ; Horkay F; Ungi I; Mansour S; Banning AP; Taggart DP; Sabaté M; Gershlick AH; Bochenek A; Pomar J; Lembo NJ; Noiseux N; Puskas JD; Crowley A; Kosmidou I; Mehran R; Ben-Yehuda O; Généreux P; Pocock SJ; Simonton CA; Stone GW; Kappetein AP
J Am Coll Cardiol; 2019 Apr; 73(13):1616-1628. PubMed ID: 30947913
[TBL] [Abstract][Full Text] [Related]
15. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
17. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial.
Diamond J; Madhavan MV; Sabik JF; Serruys PW; Kappetein AP; Leon MB; Taggart DP; Berland J; Morice MC; Gersh BJ; Kandzari DE; Dressler O; Stone GW
JACC Cardiovasc Interv; 2018 Dec; 11(24):2441-2450. PubMed ID: 30573053
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E
Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
[TBL] [Abstract][Full Text] [Related]
20. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
